Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buist, A.
Right arrow Articles by Vollmer, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Buist, A.
Right arrow Articles by Vollmer, W.

Chest, Vol 91, 119S-126S, Copyright © 1987 by American College of Chest Physicians

REVIEWS

Prospective investigations in asthma. What have we learned from longitudinal studies about lung growth and senescence in asthma?

AS Buist and WM Vollmer

The natural history of lung growth and senescence in individuals with variable air flow obstruction or clinical asthma has been given less attention than the natural history of chronic airflow obstruction. This article reviews the information available on lung growth during childhood in persons with asthma and on the rate of decline of lung function during adult life in individuals with asthma or bronchial hyperresponsiveness. Lung growth appears to be relatively normal in most children with asthma but is reduced throughout childhood and adolescence in those with severe and persistent symptoms. It is not known if this reflects a failure to reach full growth or reversible bronchoconstriction. During adult life, clinical asthma is associated with a slight increase in the rate of decline in FEV1. In the middle- aged and elderly smoker it is virtually impossible to separate chronic bronchitis and asthma. Bronchial hyperresponsiveness appears to be associated with an increase in the rate of decline of lung function but it is not clear if this is a result of airway disease due to smoking or a true risk factor. Further research needs are identified.


This article has been cited by other articles:


Home page
 NEJMHome page
P. R. Rogol, D. L. Hahn, H. A.M. Kerstjens, P. L.P. Brand, and D. S. Postma
Bronchodilator Therapy with or without Inhaled Corticosteroid Therapy for Obstructive Airways Disease
N. Engl. J. Med., April 8, 1993; 328(14): 1044 - 1045.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American College of Chest Physicians.